InvestorsHub Logo

hptaxis

01/10/12 3:37 PM

#134756 RE: dav1234 #134755

After a Year of Testing, Two Early PacBio Customers Expect More Routine Use of RS Sequencer in 2012
http://www.genomeweb.com/sequencing/after-year-testing-two-early-pacbio-customers-expect-more-routine-use-rs-sequenc

A year after receiving the PacBio RS single-molecule sequencer in their labs, early-access customers from two research institutions have taken their instruments through their paces and are starting to analyze "real" samples.

hptaxis

01/10/12 5:56 PM

#134786 RE: dav1234 #134755

Complete Genomics Misses 2011 Genome Shipment Target, Downgraded by Investment Firm
http://www.genomeweb.com/sequencing/complete-genomics-misses-2011-genome-shipment-target-downgraded-investment-firm

Complete Genomics shipped fewer genomes than forecast in the fourth quarter of 2011, and as a result was downgraded by investment firm Oppenheimer from an 'Outperform' to a 'Perform' rating.